Andrew Fein
Stock Analyst at HC Wainwright & Co.
(4.36)
# 394
Out of 5,015 analysts
597
Total ratings
49.66%
Success rate
19.55%
Average return
Main Sectors:
Stocks Rated by Andrew Fein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UTHR United Therapeutics | Maintains: Buy | $400 → $500 | $440.00 | +13.64% | 17 | Sep 5, 2025 | |
| BIIB Biogen | Maintains: Buy | $187 → $194 | $146.57 | +32.36% | 22 | Aug 1, 2025 | |
| FULC Fulcrum Therapeutics | Upgrades: Buy | $4 → $12 | $8.99 | +33.48% | 18 | Jul 29, 2025 | |
| KALV KalVista Pharmaceuticals | Reiterates: Buy | $27 | $11.50 | +134.78% | 16 | Jul 11, 2025 | |
| CADL Candel Therapeutics | Assumes: Buy | $23 | $6.19 | +271.57% | 1 | Jun 30, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $54 → $60 | $57.21 | +4.88% | 8 | Jun 26, 2025 | |
| ACAD ACADIA Pharmaceuticals | Reiterates: Buy | $32 | $20.06 | +59.52% | 20 | Jun 26, 2025 | |
| VRTX Vertex Pharmaceuticals | Reiterates: Buy | $550 | $407.79 | +34.87% | 27 | Jun 23, 2025 | |
| INSM Insmed | Maintains: Buy | $90 → $120 | $162.33 | -26.08% | 15 | Jun 11, 2025 | |
| PEPG PepGen | Maintains: Buy | $14 → $8 | $4.72 | +69.67% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $6 → $2 | $3.37 | -40.65% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $35 | $23.19 | +50.93% | 14 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $14 | $10.05 | +39.30% | 18 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $35 | $30.19 | +15.93% | 14 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $14 | $3.10 | +351.61% | 16 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $30.07 | +149.42% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $68 | $49.77 | +36.63% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $10 | $3.02 | +231.13% | 10 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $38 | $14.05 | +170.46% | 12 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $16 | $14.26 | +12.20% | 20 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $25 | $15.70 | +59.24% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $32 | $15.37 | +108.20% | 22 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $7.22 | +315.51% | 10 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $16 | $15.00 | +6.67% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $81 → $24 | $9.46 | +153.70% | 19 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $3.55 | +238.03% | 16 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $69.90 | -45.64% | 6 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $2.36 | +238.98% | 2 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $168 | $136.63 | +22.96% | 20 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $4.77 | +46.75% | 13 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $11 | $2.14 | +414.02% | 11 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.68 | +495.24% | 18 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $7.60 | +189.47% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 → $2 | $0.80 | +148.85% | 16 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $2.41 | +397.93% | 12 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $4.06 | +220.20% | 14 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $6.77 | +62.48% | 10 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $5.22 | +340.61% | 14 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $2.21 | +578.73% | 13 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $94.37 | -9.93% | 16 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $20.36 | +71.91% | 14 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $15.54 | +382.63% | 7 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $43.25 | +73.41% | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $2.25 | +211.11% | 6 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $4.77 | +109.64% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $1.71 | +8,671.93% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $200 → $60 | $18.23 | +229.13% | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $5.39 | +178.29% | 1 | Apr 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $40 | $1.42 | +2,716.90% | 3 | Mar 16, 2022 |
United Therapeutics
Sep 5, 2025
Maintains: Buy
Price Target: $400 → $500
Current: $440.00
Upside: +13.64%
Biogen
Aug 1, 2025
Maintains: Buy
Price Target: $187 → $194
Current: $146.57
Upside: +32.36%
Fulcrum Therapeutics
Jul 29, 2025
Upgrades: Buy
Price Target: $4 → $12
Current: $8.99
Upside: +33.48%
KalVista Pharmaceuticals
Jul 11, 2025
Reiterates: Buy
Price Target: $27
Current: $11.50
Upside: +134.78%
Candel Therapeutics
Jun 30, 2025
Assumes: Buy
Price Target: $23
Current: $6.19
Upside: +271.57%
Kymera Therapeutics
Jun 26, 2025
Maintains: Buy
Price Target: $54 → $60
Current: $57.21
Upside: +4.88%
ACADIA Pharmaceuticals
Jun 26, 2025
Reiterates: Buy
Price Target: $32
Current: $20.06
Upside: +59.52%
Vertex Pharmaceuticals
Jun 23, 2025
Reiterates: Buy
Price Target: $550
Current: $407.79
Upside: +34.87%
Insmed
Jun 11, 2025
Maintains: Buy
Price Target: $90 → $120
Current: $162.33
Upside: -26.08%
PepGen
May 29, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $4.72
Upside: +69.67%
May 29, 2025
Downgrades: Neutral
Price Target: $6 → $2
Current: $3.37
Upside: -40.65%
May 28, 2025
Maintains: Buy
Price Target: $29 → $35
Current: $23.19
Upside: +50.93%
May 27, 2025
Maintains: Buy
Price Target: $30 → $14
Current: $10.05
Upside: +39.30%
May 14, 2025
Maintains: Buy
Price Target: $47 → $35
Current: $30.19
Upside: +15.93%
May 14, 2025
Maintains: Buy
Price Target: $20 → $14
Current: $3.10
Upside: +351.61%
May 12, 2025
Maintains: Buy
Price Target: $80 → $75
Current: $30.07
Upside: +149.42%
May 12, 2025
Maintains: Buy
Price Target: $72 → $68
Current: $49.77
Upside: +36.63%
May 9, 2025
Maintains: Buy
Price Target: $7 → $10
Current: $3.02
Upside: +231.13%
May 9, 2025
Maintains: Buy
Price Target: $46 → $38
Current: $14.05
Upside: +170.46%
May 9, 2025
Maintains: Buy
Price Target: $12 → $16
Current: $14.26
Upside: +12.20%
May 8, 2025
Maintains: Buy
Price Target: $40 → $25
Current: $15.70
Upside: +59.24%
May 7, 2025
Maintains: Buy
Price Target: $80 → $32
Current: $15.37
Upside: +108.20%
May 6, 2025
Reiterates: Buy
Price Target: $30
Current: $7.22
Upside: +315.51%
May 5, 2025
Maintains: Buy
Price Target: $7 → $16
Current: $15.00
Upside: +6.67%
May 2, 2025
Maintains: Buy
Price Target: $81 → $24
Current: $9.46
Upside: +153.70%
May 1, 2025
Maintains: Buy
Price Target: $16 → $12
Current: $3.55
Upside: +238.03%
Apr 30, 2025
Reiterates: Buy
Price Target: $38
Current: $69.90
Upside: -45.64%
Apr 28, 2025
Reiterates: Buy
Price Target: $8
Current: $2.36
Upside: +238.98%
Apr 22, 2025
Maintains: Buy
Price Target: $185 → $168
Current: $136.63
Upside: +22.96%
Apr 4, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $4.77
Upside: +46.75%
Mar 28, 2025
Maintains: Buy
Price Target: $15 → $11
Current: $2.14
Upside: +414.02%
Mar 27, 2025
Reiterates: Buy
Price Target: $10
Current: $1.68
Upside: +495.24%
Mar 26, 2025
Reiterates: Buy
Price Target: $22
Current: $7.60
Upside: +189.47%
Mar 17, 2025
Downgrades: Neutral
Price Target: $12 → $2
Current: $0.80
Upside: +148.85%
Mar 14, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $2.41
Upside: +397.93%
Mar 7, 2025
Reiterates: Buy
Price Target: $13
Current: $4.06
Upside: +220.20%
Mar 6, 2025
Reiterates: Buy
Price Target: $11
Current: $6.77
Upside: +62.48%
Mar 6, 2025
Reiterates: Buy
Price Target: $23
Current: $5.22
Upside: +340.61%
Mar 6, 2025
Reiterates: Buy
Price Target: $15
Current: $2.21
Upside: +578.73%
Mar 3, 2025
Reiterates: Buy
Price Target: $85
Current: $94.37
Upside: -9.93%
Feb 28, 2025
Reiterates: Buy
Price Target: $35
Current: $20.36
Upside: +71.91%
Feb 18, 2025
Reiterates: Buy
Price Target: $75
Current: $15.54
Upside: +382.63%
Jan 13, 2025
Reiterates: Buy
Price Target: $75
Current: $43.25
Upside: +73.41%
Nov 2, 2023
Maintains: Buy
Price Target: $17 → $7
Current: $2.25
Upside: +211.11%
Aug 15, 2023
Reiterates: Buy
Price Target: $10
Current: $4.77
Upside: +109.64%
Jan 31, 2023
Reiterates: Buy
Price Target: $150
Current: $1.71
Upside: +8,671.93%
May 5, 2022
Downgrades: Neutral
Price Target: $200 → $60
Current: $18.23
Upside: +229.13%
Apr 27, 2022
Assumes: Buy
Price Target: $15
Current: $5.39
Upside: +178.29%
Mar 16, 2022
Maintains: Neutral
Price Target: $80 → $40
Current: $1.42
Upside: +2,716.90%